Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults

NCT02008344 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1161

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: favipiravir
DRUG: placebo

Sponsor

MDVI, LLC

Collaborators

[object Object]